Home » In the News » Press Releases » 2011 » April 28, 2011

DUSA Pharmaceuticals, Inc.® to Host First Quarter 2011 Corporate Highlights and Financial Results Webcast and Conference Call

For release at 8:30 a.m.

DUSA Pharmaceuticals, Inc.® to Host
First Quarter 2011 Corporate Highlights and
Financial Results Webcast and Conference Call

Wilmington, Mass. – April 28, 2011 - DUSA Pharmaceuticals, Inc. (NASDAQ GM: DUSA) announces that its first quarter 2011 corporate highlights and financial results press release will be issued on Thursday, May 5th at 6:30 a.m. to be followed by a conference call and audio webcast at 8:30 a.m. Conference call dial in and webcast log in details are as follows:

Thursday, May 5th - 8:30 a.m. E.D.T.
North American callers dial:
877-645-6210
International callers dial:
970-315-0447
Participant Conference ID: 63830923

To access the call online via webcast, please click here, or visit http://bit.ly/ioG9Oa.

A telephone replay will be available shortly after the live call concludes. To access the replay, dial 800-642-1687 (North American callers) or 706-645-9291 (International callers). The telephone replay and webcast will also be accessible on the investors section of our website approximately six hours following the call at www.dusapharma.com.

About DUSA Pharmaceuticals

DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company focused primarily on the development and marketing of its Levulan® PDT technology platform, and other dermatology products. Levulan® Kerastick® for topical solution plus DUSA’s BLU-U® blue light photodynamic therapy illuminator is currently approved for the treatment of minimally to moderately thick actinic keratoses (AKs) of the face or scalp. DUSA also markets other dermatology products, including ClindaReach®. DUSA is based in Wilmington, Mass. Please visit our website at www.dusapharma.com.

For further information contact:
Chad Rubin, The Trout Group LLC
Tel: 646-378-2947